CEOInterviews.AI
Start App
Try: AI strategy tariffs earnings guidance layoffs interest rates growth

Jason Hollar

CEO & Director, Cardinal Health

Search every verified Jason Hollar interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. Jason Hollar, CEO of Cardinal Health, discussed the company's performance and strategy in several appearances in late 2025. On the company's Q1 fiscal 2026 earnings call, he reported strong demand across all five operating segments, with each delivering significant double-digit earnings growth. He attributed this to the team's execution and the company's breadth of capabilities, noting particular strength in the specialty business and the successful integration of the Advanced Diabetes Supply acquisition. Hollar also highlighted that the company raised its full-year profit growth guidance to 17-19%. In a separate Fox Business interview, Hollar addressed the debate over extending Obamacare subsidies, stating the company monitors the issue daily and supports government efforts to maintain access to affordable healthcare while not sacrificing innovation. He noted that Cardinal Health is a fee-for-service organization that does not set drug prices, and expressed alignment with the administration on increasing access and affordability. Earlier in June 2025, at the company's investor day, Hollar announced investments in new distribution centers, $150 million in nuclear and precision health capacity, and the formation of a specialty alliance, while providing long-term EPS growth guidance of 12-14% through fiscal 2028.

Recent appearances

The summary and quote tags on this profile are produced with AI assistance from verified, first-person interview transcripts, then checked by our team to confirm the speaker's identity and the accuracy of every quote. See how we verify →